Suppression of urinary bladder urothelial carcinoma cell by the ethanol extract of pomegranate fruit through cell cycle arrest and apoptosis

BMC Complementary and Alternative Medicine

Volumn 13, Issue , 2013, Pages

  Lee, Song Tay ^a   Lu, Min Hua ^a   Chien, Lan Hsiang ^a   Wu, Ting Feng ^a   Huang, Li Chien ^a   Liao, Gwo Ing ^b  

^a SOUTHERN TAIWAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; CASPASE 3; CASPASE 8; CASPASE 9; CYCLIN A; CYCLIN DEPENDENT KINASE 1; DEATH RECEPTOR; POMEGRANATE EXTRACT; PROTEIN BAX;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BLADDER CARCINOMA; CANCER INHIBITION; CARCINOMA CELL; CELL DAMAGE; DRUG EFFICACY; DRUG EXPOSURE; DRUG SCREENING; ENDOPLASMIC RETICULUM; ENDOPLASMIC RETICULUM STRESS; FLOW CYTOMETRY; MITOCHONDRION; MTT ASSAY; POMEGRANATE; S PHASE CELL CYCLE CHECKPOINT; SIGNAL TRANSDUCTION; TRANSITIONAL CELL CARCINOMA; URINARY BLADDER UROTHELIAL CARCINOMA; WESTERN BLOTTING;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CARCINOMA; CELL CYCLE CHECKPOINTS; CELL LINE, TUMOR; CELL PROLIFERATION; FRUIT; HUMANS; PLANT EXTRACTS; PUNICACEAE; URINARY BLADDER NEOPLASMS;

EID: 84890528784     PISSN: None     EISSN: 14726882     Source Type: Journal    
DOI: 10.1186/1472-6882-13-364     Document Type: Article

References (25)

1. Block G, Patterson B, Subar A. Fruit, vegetables and cancer prevention: a review of the epidemiological evidence. Nutr Canc 1992, 18:1-29.
2. Mukhtar H, Ahmad N. Cancer chemoprevention: future holds in multiple agents. Toxicol Appl Pharmacol 1999, 158:207-210. 10.1006/taap.1999.8721, 10438653.
3. Parnes HL, Thompson IM, Ford LG. Prevention of hormone-related cancers: prostate cancer. J Clin Oncol 2005, 23:368-377. 10.1200/JCO.2005.08.027, 15637399.
4. Saleem M, Adhami VM, Siddiqui IA, Mukhtar H. Tea beverage in chemoprevention of prostate cancer: a mini-review. Nutr Canc 2003, 47:13-23.
5. Surh YJ. Cancer chemoprevention with dietary phytochemicals. Nat Rev Canc 2003, 3:768-780.
6. Langley P. Why a pomegranate?. BMJ 2000, 321:1153-1154. 10.1136/bmj.321.7269.1153, 1118911, 11061746.
7. Cerda B, Ceron JJ, Tomas-Barberan FA, Espin JC. Repeated oral administration of high doses of pomegranate ellagitannin punicalagin to rats for 37 days is not toxic. J Agri Food Chem 2003, 51:3493-3501.
8. Cerda B, Llorach R, Ceron JJ, Espin JC, Tomas-Barberan FA. Evaluation of the bioavailability and metabolism in the rat of punicalagin, an antioxidant polyphenol from pomegranate juice. Eur J Nutr 2003, 42:18-28. 10.1007/s00394-003-0396-4, 12594538.
9. Gil MI, Tomas-Barberan FA, Hess-Pierce B, Holcroft DM, Kader AA. Antioxidant activity of pomegranate juice and its relationship with phenolic composition and processing. J Agri Food Chem 2000, 48:4581-4589.
10. Hong MY, Seeram NP, Heber D. Pomegranate polyphenols downregulate expression of androgen synthesizing genes in human prostate cancer cells overexpressing the androgen receptor. J Nutr Biochem 2008, 19:848-855. 10.1016/j.jnutbio.2007.11.006, 2610864, 18479901.
11. Khan N, Hadi N, Afaq F, Syed DN, Kweon MH, Mukhtar H. Pomegranate fruit extract inhibits prosurvival pathways in human A549 lung carcinoma cells and tumor growth in athymic nude mice. Carcinogenesis 2007, 28:163-173. 10.1093/carcin/bgl145, 16920736.
12. Khan N, Afaq F, Kweon MH, Kim K, Mukhtar H. Oral consumption of pomegranate fruit extract inhibits growth and progression of primary lung tumors in mice. Canc Res 2007, 67:3475-3482.
13. Malik A, Afaq F, Sarfaraz S, Adhami VM, Syed DN, Mukhtar H. Pomegranate fruit juice for chemoprevention and chemotherapy of prostate cancer. Proc Natl Acad Sci U S A 2005, 102:14813-14818. 10.1073/pnas.0505870102, 1253570, 16192356.
14. Rettig MB, Heber D, An J, Seeram NP, Rao JY, Liu H, Klatte T, Belldegrun A, Moro A, Henning SM, Mo D, Aronson WJ, Pantuck A. Pomegranate extract inhibits androgen-independent prostate cancer growth through a nuclear factor-kappaB-dependent mechanism. Mol Canc Ther 2008, 7:2662-2671.
15. Sartippour MR, Seeram NP, Rao JY, Moro A, Harris DM, Henning SM, Firouzi A, Rettig MB, Aronson WJ, Pantuck AJ, Heber D. Ellagitannin-rich pomegranate extract inhibits angiogenesis in prostate cancer in vitro and in vivo. Int J Oncol 2008, 32:475-480.
16. Pantuck AJ, Leppert JT, Zomorodian N, Aronson W, Hong J, Barnard RJ, Seeram N, Liker H, Wang H, Elashoff R, Heber D, Aviram M, Ignarro L, Belldegrun A. Phase II study of pomegranate juice for men with rising prostate-specific antigen following surgery or radiation for prostate cancer. Clin Canc Res 2006, 12:4018-4026.
17. Bane BL, Rao JY, Hemstreet GP. Pathology and staging of bladder cancer. Semin Oncol 1996, 23:546-570.
18. Stein JP, Grossfeld GD, Ginsberg DA, Esrig D, Freeman JA, Figueroa AJ, Skinner DG, Cote RJ. Prognostic markers in bladder cancer: a contemporary review of the literature. J Urol 1998, 160:645-659. 10.1016/S0022-5347(01)62747-2, 9720515.
19. Zieger K, Wolf H, Olsen PR, Hojgaard K. Long-term follow-up of noninvasive bladder tumours (stage Ta): recurrence and progression. BJU Int 2000, 85:824-828.
20. Chen SH, Wang YW, Hsu JL, Chang HY, Wang CY, Shen PT, Chiang CW, Chuang JJ, Tsai HW, Gu PW, Chang FC, Liu HS, Chow NH. Nucleophosmin in the pathogenesis of arsenic-related bladder carcinogenesis revealed by quantitative proteomics. Toxicol Appl Pharmacol 2010, 242:26-35.
21. Bendris N, Lemmers B, Blanchard JM, Arsic N. Cyclin A2 mutagenesis analysis: a new insight into CDK activation and cellular localization requirements. PLoS ONE 2011, 6:e22879. 10.1371/journal.pone.0022879, 3145769, 21829545.
22. Yam CH, Fung TK, Poon RY. Cyclin A in cell cycle control and cancer. Cell Mol Life Sci 2002, 59:1317-1326. 10.1007/s00018-002-8510-y, 12363035.
23. Braun RJ, Zischka H. Mechanisms of Cdc48/VCP-mediated cell death: from yeast apoptosis to human disease. Biochim Biophys Acta 2008, 1783:1418-1435. 10.1016/j.bbamcr.2008.01.015, 18284922.
24. Chen YC, Su HJ, Guo YL, Hsueh YM, Smith TJ, Ryan LM, Lee MS, Christiani DC. Arsenic methylation and bladder cancer risk in Taiwan. Canc Causes Contr 2003, 14:303-310.
25. Shi C, Yu L, Yang F, Yan J, Zeng H. A novel organoselenium compound induces cell cycle arrest and apoptosis in prostate cancer cell lines. Biochem Biophys Res Commun 2003, 2003(309):578-583.